Wegovy (semaglutide) is a GLP-1 receptor agonist prescribed for chronic weight management in the UK
By comparison, oral B12 supplements are absorbed at roughly 1 to 5% in healthy adults, and even less if you have low intrinsic factor, atrophic gastritis, celiac disease, Crohn's, or a history of gastric bypass
Today in #Employer Coverage: GLP-1 drugs do not lead to lower medical costs in the short run and are not likely to lead to lower medical costs even over a longer time horizon unless prices are substantially reduced
In a recent review published in the journal Obesity Pillars , a team of researchers collate and narratively review the literature on the dietary impacts of obesity or type 2 diabetes (T2D) patients undergoing glucagon-like peptide receptor agonists (GLP-1RAs) or glucose-dependent insulinotropic polypeptide/glucagon-like peptide receptor agonists (GIP/GLP-1RAs) clinical interventions
They work by regulating appetite, improving fat metabolism, enhancing energy use, and preserving lean muscle
The $99 Precision Peptide Genetic Test analyzes peptide pathway variants rather than contraindications, helping identify which GLP-1 compound or dose strategy works best for your biology
